My investment thesis affirms a strong buy recommendation for Lam Research (LRCX). The decision to slightly lower the price target from $497 to $455 is a strategic adjustment due to the revised forward non-GAAP P/E ratio. The company's fourth-quarter 2026 financial performance exceeded all forecasts, which has prompted an increase in the projected forward non-GAAP earnings per share (EPS) to $9.1. This projection is underpinned by a cautious 50x P/E multiple, reflecting a balanced outlook on future valuation.
Previously, my financial model estimated the forward non-GAAP EPS at $7.26. However, subsequent to the robust Q1 2027 guidance provided by Lam Research, this estimate has been revised upwards to $9.1. This positive recalibration underscores the company's strong operational momentum and promising outlook. Despite these optimistic adjustments, it is important to acknowledge certain inherent risks that could influence the company's trajectory. These include a potential deceleration in wafer fabrication equipment (WFE) expenditures, a downturn in memory investment, the ongoing impact of China-related trade restrictions, and the possibility that LRCX's stock multiple may not deviate significantly from its present valuation.
Lam Research stands as a compelling investment opportunity, balancing robust financial performance with strategic market positioning. The recent adjustments to its price target and EPS forecasts reflect a dynamic and responsive analytical approach. Investors should consider the company's consistent outperformance and its capacity for growth within the evolving semiconductor industry, while remaining mindful of the identified market and geopolitical risks. This analysis reaffirms a positive long-term outlook for LRCX, emphasizing its continued potential for strong returns.
